Pharmacy Reviews
A medication review on a workers compensation or CTP claim only carries weight if the pharmacist is impartial. IMM reviews come from accredited pharmacists who never dispense or work for the insurer.
What does a medication review on a workers compensation claim deliver?
A medication review on a workers compensation or CTP claim examines the injured person's full medication profile, including both claim-related and non-claim medication, to identify interactions, duplication, high-risk combinations, and opportunities to simplify treatment. IMM works directly with treating practitioners to agree a path forward, then returns a report scoped to the objectives the case manager has set.
- Comprehensive analysis of interactions between claim and non-claim medication.
- Targeted, practitioner-ready recommendations rather than generic commentary.
- A clear medication titration plan where ongoing high-risk medication needs to be reduced.
- Reports scoped to the specific clinical and liability questions on the claim.
- Implementation support, so a recommendation does not stop at the page.
How does independence change the review?
IMM pharmacists provide review and advice. They do not dispense or supply medication. That distinction matters, because a provider that both reviews a medication profile and profits from supplying those medications carries an inherent conflict of interest. A conflict-free medication review removes that problem entirely, leaving one role only: the safest, most defensible clinical position on the claim.
What goes into the report?
Each report from an independent medication review insurer partner is written for action, not filing. It states the clinical concern, the recommendation, and where relevant the titration steps the treating GP or specialist can follow, all tied back to the questions the claim actually raises rather than a generic template.
How are reviews built for scheme requirements?
Reviews are structured for Australian personal injury schemes, including workers compensation and CTP, and align with scheme expectations for clinical justification and documented decision-making. Where a claim moves toward a liability or medico-legal question, the pharmacy review provides the standard of evidence those decisions require.
When should you refer a claim?
Refer when the medication picture has grown complex: three or more centrally acting medications, opioids or benzodiazepines continuing beyond the expected window, or a clinical pharmacist injury claim question that the file cannot answer on its own. Tell IMM the objectives and the report comes back tailored to them.
Key Takeaways
- A medication review weighs the full profile, claim and non-claim, not just the injury medication.
- Independence comes from not dispensing and not being employed by the insurer.
- Reports are practitioner-ready, with titration plans where high-risk medication needs to reduce.
- Reviews are built for workers compensation and CTP scheme evidence requirements.
- The strongest case for referral is a complex or contested medication picture.
- IMM records an 81% prescriber implementation rate and an 8-day average turnaround.
Frequently Asked Questions
What does an independent medication review cover?
It examines the injured person's full medication profile, claim-related and non-claim, to find interactions, duplication, high-risk combinations and chances to simplify treatment, then sets out practitioner-ready recommendations scoped to the claim objectives.
What makes the review independent?
IMM pharmacists provide review and advice only. They do not dispense or supply medication and are not employed by the insurer, so the recommendation carries no commercial interest in what is supplied.
How quickly is a report returned?
IMM records an 8-day average turnaround across more than 10,000 assessments, and timeframes can be scoped to the urgency of the claim when you refer.
Does the review include a plan to reduce high-risk medication?
Yes. Where ongoing high-risk medication needs to come down, the report includes a clear titration plan the treating practitioner can action, with implementation support so the recommendation does not stop at the page.
Primary source: Pharmaceutical Society of Australia (PSA), Guidelines for pharmacists providing medicines review services, 2022.
